Loading...
Research Project
Controlling the degradation of MAGnesium alloys for biomedical applications using Innovative smart COATings
Funder
Authors
Publications
Insights into corrosion behaviour of uncoated Mg alloys for biomedical applications in different aqueous media
Publication . Neves, C.S.; Sousa, I.; Freitas, M.A.; Moreira, L.; Costa, C.; Teixeira, J.P.; Fraga, S.; Pinto, E.; Almeida, A.; Scharnagl, N.; Zheludkevich, M.L.; Ferreira, M.G.S.; Tedim, J.
MgCa and MgGd series of alloys are often reported as promising candidates for biomedical
applications. In the present study, cytotoxicity and corrosion behavior of Mg1Ca and
Mg10Gd alloys in different electrolytes (NaCl, PBS, MEM) have been investigated in order to
make a direct comparison and understand the mechanisms behind their performance.
Potentiodynamic polarization and electrochemical impedance spectroscopy (EIS) were
employed to analyze corrosion processes depending on media composition, whereas X-Ray
diffraction (XRD) and scanning electron microscopy (SEM) were used to evaluate crystalline
structure, phase composition and surface morphology of the corroded substrates after
immersion in the different electrolytes. Moreover, cytotoxicity of the Mg alloys was
assessed using the WST-1 reduction and lactate dehydrogenase (LDH) release assays in
L929 mouse fibroblasts. The electrochemical results showed that Mg1Ca has a lower
degradation rate when compared to Mg10Gd, due to the lower microgalvanic effects and
the presence of Ca as an alloying element. Furthermore, the corrosion activity is reduced in
MEM, for both alloys, when compared to NaCl and PBS. The cytotoxicity assays revealed
that Mg10Gd was cytotoxic in all the conditions tested, while the toxicity of Mg1Ca was
low. Overall, these findings show that Mg1Ca alloy presents a higher corrosion resistance
and biocompatibility and is a promising material to be used in biomedical implants.
Organizational Units
Description
Keywords
Contributors
Funders
Funding agency
Fundação para a Ciência e a Tecnologia
Funding programme
9471 - RIDTI
Funding Award Number
PTDC/CTM-BIO/2170/2014
